Kymera Therapeutics listed its stock on the Nasdaq exchange on May 27, 2026.
8 reports, 3 independent
Updated Sep 4
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 8
- Developments
- 2
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kymera Therapeutics listed its stock on the Nasdaq exchange on May 27, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Kymera Therapeutics listed its shares on the Nasdaq exchange.1 source
Kymera Therapeutics listed its stock on the Nasdaq exchange on May 27, 2026, and made SEC filings.1 source
Keep exploring
The entities involved
-
Kymera Therapeutics
biopharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Connect Biopharma listed its stock on the Nasdaq exchange on August 1, 2026.
- Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Evelo Biosciences listed its stock on the Nasdaq exchange on August 1, 2026.
- BrightSpring Health Services stock is trading on the Nasdaq exchange.